Meson Capital and Argonne Capital Group offer $3.75 per share for InfuSystem

Author's Avatar
Apr 12, 2019
Article's Main Image
  • Calls on Board to Act in the Best Interest of Shareholders in Evaluating Going-Private Transaction
  • Believes Strategic Review is Necessary to Maximize Value Creation
  • Nominates Slate of Highly Qualified Director Candidates for Election at the Upcoming Annual Meeting to Address the Challenges and Opportunities Facing the Company